Literature DB >> 11174945

Quantitative Echocardiographic Assessment in Pericardial Disease.

Afzal Ur Rehman, Holly L. Hancock.   

Abstract

Although echocardiography has been used for diagnosing pericardial effusions since 1965, the grading of such effusions for size, and also the diagnosis of tamponade have depended almost entirely on qualitative observations or "signs." The categorization of pericardial effusions into small, moderate, or large according to the width of pericardial space is very roughly semiquantitative. Diagnostic criteria for tamponade are based on altered ventricular or atrial wall contour, and on phasic respiratory fluctuations of ventricular size and flow velocities. We review a new approach to pericardial effusion volume estimation, based on assessing the pericardial sac volume as well as cardiac volume by the ellipsoid formula. A new quantitative criteria for tamponade (i.e., biatrial width to cardiac width) (annular level) ratio may be useful, a ratio < 0.85 indicating tamponade, reflecting late diastolic biatrial collapse. The echo diagnosis of pericardial constriction depends on pericardial thickening combined with various abnormalities of septal and ventricular wall motion, some of them subtle. We review a new two-dimensional echo "sign" present in some cases of pericardial constriction: abnormal posterior displacement of the left atrial posterior wall, and reduced angle (<150 degrees ) between it and left ventricular wall in long-axis view. Measurements reflecting the fluctuation of certain Doppler parameters can also be useful in diagnosis of this entity.

Entities:  

Year:  1997        PMID: 11174945     DOI: 10.1111/j.1540-8175.1997.tb00712.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  9 in total

1.  Epicardial halo phenomenon: a guide for pericardiocentesis?

Authors:  Arsen D Ristić; Hans-Joachim Wagner; Ružica Maksimović; Bernhard Maisch
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

Review 2.  Neoplastic pericardial effusion.

Authors:  Marwan M Refaat; William E Katz
Journal:  Clin Cardiol       Date:  2011-09-16       Impact factor: 2.882

Review 3.  Superior Vena Cava Rupture and Cardiac Tamponade Complicating the Endovascular Treatment of Malignant Superior Vena Cava Syndrome: A Case Report and Literature Review.

Authors:  David C Stevens; Sabah Butty; Matthew S Johnson
Journal:  Semin Intervent Radiol       Date:  2015-12       Impact factor: 1.513

4.  Large pericardial effusion requiring pericardiocentesis as cardinal sign of macrophage activation syndrome in systemic onset-juvenile idiopathic arthritis.

Authors:  Donato Rigante; Gabriella De Rosa; Barbara Bertoni; Valentina Ansuini; Manuela Pardeo; Ilaria La Torraca; Stefania Gaspari; Achille Stabile
Journal:  Rheumatol Int       Date:  2006-12-08       Impact factor: 3.580

5.  Effectiveness of computed tomography attenuation values in characterization of pericardial effusion.

Authors:  Mehmet Serkan Çetin; Elif Hande Özcan Çetin; Mustafa Özdemir; Serkan Topaloğlu; Dursun Aras; Ahmet Temizhan; Sinan Aydoğdu
Journal:  Anatol J Cardiol       Date:  2017-01-17       Impact factor: 1.596

6.  Pediatric Emergency Medicine Simulation Curriculum: Cardiac Tamponade.

Authors:  Julie A Augenstein; Jason Deen; Anita Thomas; Emily Moser; Kimberly Stone; Jennifer Reid; Rebekah Burns
Journal:  MedEdPORTAL       Date:  2018-09-28

7.  Unusual presentation of pericardial effusion.

Authors:  Sanjith Saseedharan; Suyash Kulkarni; Rahul Pandit; Dilip Karnad
Journal:  Indian J Crit Care Med       Date:  2012-10

8.  Improved hyponatremia after pericardial drainage in patients suffering from cardiac tamponade.

Authors:  Bor-Hsin Jong; Cheng-Chun Wei; Kou-Gi Shyu
Journal:  BMC Cardiovasc Disord       Date:  2016-06-11       Impact factor: 2.298

9.  Predictors and Outcome of Pericardial Effusion After Hematopoietic Stem Cell Transplantation in Children.

Authors:  A B Versluys; H B Grotenhuis; M J J Boelens; A M C Mavinkurve-Groothuis; J M P J Breur
Journal:  Pediatr Cardiol       Date:  2017-10-23       Impact factor: 1.655

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.